DK1067933T3 - Semisyntetiske ecteinascidiner - Google Patents

Semisyntetiske ecteinascidiner

Info

Publication number
DK1067933T3
DK1067933T3 DK99916379T DK99916379T DK1067933T3 DK 1067933 T3 DK1067933 T3 DK 1067933T3 DK 99916379 T DK99916379 T DK 99916379T DK 99916379 T DK99916379 T DK 99916379T DK 1067933 T3 DK1067933 T3 DK 1067933T3
Authority
DK
Denmark
Prior art keywords
ecteinascidins
semisynthetic
bioactivities
boc
species
Prior art date
Application number
DK99916379T
Other languages
Danish (da)
English (en)
Inventor
Kenneth L Rinehart
Jose J Morales
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Application granted granted Critical
Publication of DK1067933T3 publication Critical patent/DK1067933T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyrane Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Dental Preparations (AREA)
  • Hydrogenated Pyridines (AREA)
DK99916379T 1998-04-06 1999-04-05 Semisyntetiske ecteinascidiner DK1067933T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8080298P 1998-04-06 1998-04-06
PCT/US1999/007471 WO1999051238A1 (en) 1998-04-06 1999-04-05 Semi-synthetic ecteinascidins

Publications (1)

Publication Number Publication Date
DK1067933T3 true DK1067933T3 (da) 2007-12-27

Family

ID=22159716

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99916379T DK1067933T3 (da) 1998-04-06 1999-04-05 Semisyntetiske ecteinascidiner

Country Status (27)

Country Link
US (1) US6124293A (cs)
EP (2) EP1876180A3 (cs)
JP (1) JP4443043B2 (cs)
KR (1) KR100603219B1 (cs)
CN (1) CN1157189C (cs)
AT (1) ATE370148T1 (cs)
AU (1) AU758100B2 (cs)
BG (1) BG65088B1 (cs)
BR (1) BR9909488B1 (cs)
CA (1) CA2327468C (cs)
CY (1) CY1106988T1 (cs)
CZ (1) CZ301083B6 (cs)
DE (1) DE69936845T2 (cs)
DK (1) DK1067933T3 (cs)
ES (1) ES2292237T3 (cs)
HU (1) HUP0104273A3 (cs)
IL (2) IL138856A0 (cs)
MX (1) MXPA00009840A (cs)
NO (1) NO328147B1 (cs)
NZ (1) NZ507350A (cs)
PL (1) PL196809B1 (cs)
PT (1) PT1067933E (cs)
RU (1) RU2217432C2 (cs)
SK (1) SK285669B6 (cs)
TR (1) TR200002921T2 (cs)
UA (1) UA59439C2 (cs)
WO (1) WO1999051238A1 (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985876A (en) * 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
CA2331593C (en) * 1998-05-11 2008-08-05 Pharma Mar, S.A. Metabolites of ecteinascidin 743
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
AR035842A1 (es) * 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
AU783562B2 (en) * 2000-01-19 2005-11-10 Trustees Of Columbia University In The City Of New York, The Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
WO2002040477A2 (en) 2000-11-03 2002-05-23 President And Fellows Of Harvard College Saframycins, analogues and uses thereof
CZ20031327A3 (cs) * 2000-11-06 2003-11-12 Pharma Mar, S. A. Užití ET-743 k výrobě léků pro účinnou protinádorovou léčbu
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) * 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
GB0202544D0 (en) 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
DE602004016376D1 (de) 2003-11-13 2008-10-16 Pharma Mar Sau Kombination von et-743 mit 5-fluorouracil pro-drugs zur behandlung von krebs
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
CN1897949A (zh) * 2003-11-14 2007-01-17 马尔药品公司 包含使用et-743和紫杉醇来治疗癌症的联合疗法
AU2005261860A1 (en) * 2004-07-09 2006-01-19 Pharma Mar, S.A. Use of ecteinascidin in the treatment of cancer in patients with low level of BRCA1
JP2008514688A (ja) * 2004-09-29 2008-05-08 ファルマ・マル・エス・アー, ソシエダッド・ユニペルソナル 抗炎症剤としてのエクテイナシジン化合物
RU2359700C2 (ru) * 2004-10-26 2009-06-27 Фарма Мар С.А., Сосьедад Униперсональ Пегилированный липосомальный доксорубицин в комбинации с эктеинасцидином 743 (ecteinescidin 743)
ATE368461T1 (de) 2004-10-29 2007-08-15 Pharma Mar Sa Zusammensetzungen enthaltend ecteinascidin und einen disaccharide
GB0522082D0 (en) 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CN100355775C (zh) * 2006-01-20 2007-12-19 南方医科大学 一种海鞘多肽及其制备方法
EP2201141A1 (en) * 2007-10-19 2010-06-30 Pharma Mar S.A. Prognostic molecular markers for et-743 treatment
BR112013011480B1 (pt) 2010-11-12 2022-03-22 Pharma Mar, S.A Uso de pm01183 ou um sal farmaceuticamente aceitável do mesmo e kit para uso no tratamento de câncer
KR20180103965A (ko) * 2016-02-04 2018-09-19 지앙수 헨그루이 메디슨 컴퍼니 리미티드 위장관 외용을 위한 트라벡테딘-함유 주사가능한 약학적 조성물 및 그의 제조 방법
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN118924689A (zh) 2019-11-21 2024-11-12 法马马有限公司 用鲁比卡丁制剂治疗小细胞肺癌的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5149804A (en) * 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
TW221441B (cs) * 1991-01-25 1994-03-01 Taiho Pharmaceutical Co Ltd
US5440055A (en) * 1993-03-12 1995-08-08 Aphios Corporation Method and apparatus for extracting taxol from source materials
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds

Also Published As

Publication number Publication date
DE69936845T2 (de) 2008-05-08
KR20010074474A (ko) 2001-08-04
SK15012000A3 (sk) 2001-08-06
CA2327468C (en) 2008-05-06
CZ301083B6 (cs) 2009-11-04
CZ20003650A3 (en) 2001-06-13
CN1157189C (zh) 2004-07-14
ATE370148T1 (de) 2007-09-15
JP2002510633A (ja) 2002-04-09
EP1067933B1 (en) 2007-08-15
NZ507350A (en) 2003-03-28
US6124293A (en) 2000-09-26
JP4443043B2 (ja) 2010-03-31
EP1876180A2 (en) 2008-01-09
DE69936845D1 (de) 2007-09-27
SK285669B6 (sk) 2007-06-07
KR100603219B1 (ko) 2006-07-20
BR9909488B1 (pt) 2011-02-08
CY1106988T1 (el) 2012-09-26
PL343439A1 (en) 2001-08-13
EP1067933A1 (en) 2001-01-17
BG104902A (en) 2001-07-31
PL196809B1 (pl) 2008-02-29
NO328147B1 (no) 2009-12-21
TR200002921T2 (tr) 2001-02-21
EP1067933A4 (en) 2002-12-18
IL138856A (en) 2007-07-24
HK1033651A1 (en) 2001-09-14
WO1999051238A1 (en) 1999-10-14
AU3471399A (en) 1999-10-25
CN1304309A (zh) 2001-07-18
EP1876180A3 (en) 2009-12-16
HUP0104273A3 (en) 2003-12-29
BG65088B1 (bg) 2007-02-28
MXPA00009840A (es) 2002-04-24
AU758100B2 (en) 2003-03-13
UA59439C2 (uk) 2003-09-15
PT1067933E (pt) 2007-11-15
BR9909488A (pt) 2000-12-26
WO1999051238A9 (en) 2000-01-27
NO20004978D0 (no) 2000-10-03
RU2000128058A (ru) 2004-02-20
IL138856A0 (en) 2001-10-31
HUP0104273A2 (hu) 2002-03-28
ES2292237T3 (es) 2008-03-01
NO20004978L (no) 2000-12-05
CA2327468A1 (en) 1999-10-14
RU2217432C2 (ru) 2003-11-27

Similar Documents

Publication Publication Date Title
DK1067933T3 (da) Semisyntetiske ecteinascidiner
EA199900936A1 (ru) Фунгицидные трифторметилалкиламинотриазолопиримидины
CL2004001072A1 (es) Compuestos derivados de trifluorofenil-triazolopirimidina; procedimiento de preparacion de los compuestos; compuestos intermediarios utiles como fungicidas.
TR200000065T2 (tr) Epotilon türevleri.
ES2069137T3 (es) Derivados de imidazopiridina y su uso.
NO902394L (no) Fremgangsmaate for fremstilling av pyranyl-cyanoguanidin-derivater.
DE69022368D1 (de) Quinolin-3-carboxanilid-derivate.
DE3683922D1 (de) Chinolinderivate.
DE60013994D1 (de) 1,2-Disubstituierte 1,4-Dihydro-4-oxochinolin-Verbindungen
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
ATE73768T1 (de) 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8inter-m-phenylene-pgi2-derivate.
ATE93846T1 (de) S-substituierte beta-thioacrylamide und deren verwendung als mikrobizide.
EA200200026A1 (ru) ПРОИЗВОДНЫЕ 4'-ДЕМИКАРОЗИЛ-8а-АЗА-8а-ГОМОТИЛОЗИНА
WO2000075158A3 (en) NOVEL 6-PHENYLPURINE 9-β-D-RIBONUCLEOSIDES WITH ANTINEOPLASTIC ACTIVITY, THEIR USE FOR PREPARING PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
SE8700566D0 (sv) Tetracyclic quinazolinones
FR2597105B1 (fr) Derives antibiotiques de la famille des 20-0-acyl-19,20-enolmacrolides
DE69020576D1 (de) 1,4-bis(alkylamino)-2,3-diaza-anthracen-9,10-dione.
NZ314554A (en) Arylthio, -sulphinyl and -sulphonyl pyrrole derivatives, and insecticidal compositions thereof
EP0264951A3 (en) Procaterol-derivatives
SU1351062A1 (ru) Производные шестичленных циклических эфиров, ингибирующие рост золотистого стафилококка